Knee Endoprosthesis Is Fastest Growing Segment Fueling The Growth Of Endoprosthesis Market
The endoprosthesis market comprises of various medical devices that are implanted
inside the human body to replace or repair a diseased or damaged biological
structure. These include various forms of implants such as knee endoprostheses,
hip endoprostheses, shoulder endoprostheses and more. Knee endoprosthesis is
the fastest-growing segment owing to the increasing incidence of osteoarthritis
and other knee disorders globally.
The global Endoprosthesis Market is
estimated to be valued at US$ 21.50 Bn
in 2023 and is expected to exhibit a CAGR
of 7.5% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market key trends:
Minimally invasive surgeries (MIS) are gaining rapid traction in the
endoprosthesis market. MIS involves fewer cuts, shorter hospital stays, less
pain and faster recovery times compared to open surgeries. Additionally,
customized and 3D printed endoprosthetics have emerged as a key trend.
Customized implants are designed based on the patient's anatomy using medical
imaging and 3D modeling softwares for a perfect fit. This improves placement accuracy
and long term outcomes.
Segment Analysis
The global endoprosthesis market is segmented based on product, material,
application, and end-user. Based on product, the market is segmented into lower
extremity endoprosthesis, upper extremity endoprosthesis, and sockets. The
lower extremity endoprosthesis segment dominates the market as advancements in
better material design have enabled the development of more functional lower
extremity endoprostheses to closely mimic mobility and properties of the
natural limb.
Key Takeaways
The global Endoprosthesis
Market Size is expected to witness high growth, exhibiting CAGR of 7.5%
over the forecast period, due to increasing number of trauma, injury, and
disease-related amputations across the globe.
Regional analysis: North America dominates the endoprosthesis market currently,
owing to advanced healthcare infrastructure and high adoption rate of new
technologies in the region. Asia Pacific is expected to grow at the fastest
rate during the forecast period. This can be attributed to rising geriatric
population, increase in healthcare expenditures, and improving medical
facilities in developing countries such as India and China.
Key players: Key players operating in the endoprosthesis market are Medtronic,
Boston Scientific, Abbott Laboratories, Edwards Lifesciences, Johnson &
Johnson, Stryker, Zimmer Biomet, Smith & Nephew, BD, and Teleflex.
Medtronic and Zimmer Biomet are the market leaders due to their innovative
product portfolio and strong global presence across countries.
Comments
Post a Comment